Patents, a form of intellectual property (IP), are filed on many discoveries or inventions that are produced by CGDN scientists. When IP is out-licensed to organizations that have a vested interest in developing it, CGDN receives benefits in the form of royalty fees or equity.

The following is a comprehensive list of our intellectual property that is currently available for licensing.

	Current Intellectual Property Available for Licensing
	Role of hormone sensitive lipase in male fertility Method for enrichment of fetal cells from maternal blood and use of same in determination of fetal sex and detection of chromosomal abnormalities

If you have questions or concerns regarding any of CGDN’s protected technology, please contact the Canadian Genetic Disease Network.

Dr. Louise Desjardins, Business Development Manager
Phone: (613) 841-7546
Cell: (613) 851-5246
Fax: (613) 841-2614
Email: [email protected]